List view / Grid view


Kymab and the Wellcome Trust initiate Ebola Project

16 December 2014 | By Kymab

Kymab, a monoclonal antibody biopharmaceutical company, founded on research from the Wellcome Trust Sanger Institute announces that it has been awarded a grant from the Wellcome Trust to lead a consortium developing new treatments in the fight against Ebola...

New targeted drugs could treat drug-resistant skin cancer

15 December 2014 | By The Institute of Cancer Research, London, and Cancer Research UK Manchester Institute

A brand new family of cancer drugs designed to block several key cancer-causing proteins at once could potentially treat incurable skin cancers, a major new study reports...